This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.

25% lower NHS list price vs Humalog cartridges and pre-filled pens and 15% lower NHS list price vs Humalog vials2

1:1 initial unit dosing* – available in the SoloSTAR® pen, cartridges and vials1

*Changes in strength, brand, type, species and/or method of manufacture may result in the need for a change in dosage. Transferring to a different insulin should be done under strict medical supervision.

Similar PK/PD profile (T1DM)3, efficacy, safety and tolerability profiles (T1DM and T2DM)4-5

    DSN, diabetes specialist nurse; EU, European Union, NHS, National Health Service; PD, pharmacodynamic; PK, pharmacokinetic; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; UK, United Kingdom.


    1. Admelog SmPC October 2021
    2. The NHS Dictionary of Medicines and Devices Admelog: solution for injection. Available at: Last accessed: November 2022
    3. Kapitza C, et al. Diabetes Obes Metab. 2017;19(5):622–7.
    4. Garg SK, et al. Diabetes Technol Ther. 2017;19(9):516–26
    5. Derwahl K, et al. Diabetes Technol Ther. 2018;20(1):1–10.
    6. Garg SK, et al. Diabetes Technol Ther. 2017;19(9):516–26
    7. Derwahl K, et al. Diabetes Technol Ther. 2018;20(1):1–10.

Diabetes Stories

Watch peer-to-peer videos of payors and healthcare professionals sharing best practices of adopting a rapid acting insulin biosimilar.
Some of these videos are related to HCPs sharing their experiences with a different rapid acting insulin biosimilar.


Start and Switch

Watch and download resources to support your rapid acting insulin adoption.

  • What is a biosimilar medicine?

    Length: 07:00

    Some healthcare professionals require an extra reassurance on biosimilars. Learn from Grace Vanterpool explain what a biosimilar insulin is, how it works and performs and why should the NHS use biosimilar insulin, to support you in making a positive adoption with Trurapi.

  • Admelog Leaflet

    An overview of the clinical evidence, price comparison of Admelog® versus Humalog® and information on dosing and the different presentations available.

  • Formulary FAQ

    Factual and technical information about Admelog to support you with relevant documentation for local formulary applications.

  • Admelog Poster

    Pharmacists and other Healthcare Professionals can print this poster and put it in drug fridges to provide information about Admelog®.

  • Diabetes Stories

    Length: 04:02

    Starting or switching to a rapid acting insulin biosimilar can raise some concerns from healthcare professionals and patients. Watch how a payor, an endocrinologist and a diabetes specialist nurse implemented a rapid acting biosimilar insulin in their local region and how they collaborated with clinical teams and patients to make a positive start and switch

Get in touch with the Diabetes Team

MAT-XU-2201545 (v3.0)
Date of Preparation: February 2023

MAT-GB-2105789 (v6.0)
Date of Preparation: February 2023